These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical Saccharomyces cerevisiae isolates cannot cross the epithelial barrier in vitro. Pérez-Torrado R; Llopis S; Jespersen L; Fernández-Espinar T; Querol A Int J Food Microbiol; 2012 Jun; 157(1):59-64. PubMed ID: 22609000 [TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
4. Traversal of Candida albicans across human blood-brain barrier in vitro. Jong AY; Stins MF; Huang SH; Chen SH; Kim KS Infect Immun; 2001 Jul; 69(7):4536-44. PubMed ID: 11401997 [TBL] [Abstract][Full Text] [Related]
5. Immunoproteomic profiling of Saccharomyces cerevisiae systemic infection in a murine model. Hernández-Haro C; Llopis S; Molina M; Monteoliva L; Gil C J Proteomics; 2015 Jan; 112():14-26. PubMed ID: 25173100 [TBL] [Abstract][Full Text] [Related]
6. Transcriptomics in human blood incubation reveals the importance of oxidative stress response in Saccharomyces cerevisiae clinical strains. Llopis S; Querol A; Heyken A; Hube B; Jespersen L; Fernández-Espinar MT; Pérez-Torrado R BMC Genomics; 2012 Aug; 13():419. PubMed ID: 22916735 [TBL] [Abstract][Full Text] [Related]
8. Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae. Zavrel M; Hoot SJ; White TC Eukaryot Cell; 2013 May; 12(5):725-38. PubMed ID: 23475705 [TBL] [Abstract][Full Text] [Related]
9. Probiotic Yeasts Inhibit Virulence of Non Kunyeit L; Kurrey NK; Anu-Appaiah KA; Rao RP mBio; 2019 Oct; 10(5):. PubMed ID: 31615960 [TBL] [Abstract][Full Text] [Related]
10. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607 [TBL] [Abstract][Full Text] [Related]
11. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. McKenzie H; Main J; Pennington CR; Parratt D Gut; 1990 May; 31(5):536-8. PubMed ID: 2190866 [TBL] [Abstract][Full Text] [Related]
12. Sugar Sensing and Signaling in Van Ende M; Wijnants S; Van Dijck P Front Microbiol; 2019; 10():99. PubMed ID: 30761119 [No Abstract] [Full Text] [Related]
13. Discriminative power of fatty acid methyl ester (FAME) analysis using the microbial identification system (MIS) for Candida (Torulopsis) glabrata and Saccharomyces cerevisiae. Peltroche-Llacsahuanga H; Schmidt S; Lütticken R; Haase G Diagn Microbiol Infect Dis; 2000 Dec; 38(4):213-21. PubMed ID: 11146246 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Cochaperone Mge1 Is Involved in Regulating Susceptibility to Fluconazole in Demuyser L; Swinnen E; Fiori A; Herrera-Malaver B; Vestrepen K; Van Dijck P mBio; 2017 Jul; 8(4):. PubMed ID: 28720726 [No Abstract] [Full Text] [Related]
15. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. Junqueira JC; Fuchs BB; Muhammed M; Coleman JJ; Suleiman JM; Vilela SF; Costa AC; Rasteiro VM; Jorge AO; Mylonakis E BMC Microbiol; 2011 Nov; 11():247. PubMed ID: 22053894 [TBL] [Abstract][Full Text] [Related]
16. Glutathione biosynthesis in the yeast pathogens Candida glabrata and Candida albicans: essential in C. glabrata, and essential for virulence in C. albicans. Yadav AK; Desai PR; Rai MN; Kaur R; Ganesan K; Bachhawat AK Microbiology (Reading); 2011 Feb; 157(Pt 2):484-495. PubMed ID: 20966090 [TBL] [Abstract][Full Text] [Related]
17. A Novel Hybrid Iron Regulation Network Combines Features from Pathogenic and Nonpathogenic Yeasts. Gerwien F; Safyan A; Wisgott S; Hille F; Kaemmer P; Linde J; Brunke S; Kasper L; Hube B mBio; 2016 Oct; 7(5):. PubMed ID: 27795405 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. Arzeni D; Del Poeta M; Simonetti O; Offidani AM; Lamura L; Balducci M; Cester N; Giacometti A; Scalise G Eur J Epidemiol; 1997 Jun; 13(4):447-50. PubMed ID: 9258552 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in mice. Dubois N; Colina AR; Aumont F; Belhumeur P; de Repentigny L Microbiology (Reading); 1998 Aug; 144 ( Pt 8)():2299-2310. PubMed ID: 9720053 [TBL] [Abstract][Full Text] [Related]
20. Antagonistic effect of Saccharomyces cerevisiae KTP and Issatchenkia occidentalis ApC on hyphal development and adhesion of Candida albicans. Lohith K; Anu-Appaiah KA Med Mycol; 2018 Nov; 56(8):1023-1032. PubMed ID: 29340656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]